N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine
C24H22N6S — CID 121275228
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine
N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine (PubChem CID 121275228) has the molecular formula C24H22N6S and a molecular weight of 426.55 g/mol. Its IUPAC name is N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine.
Molecular Properties
| Compound Name | N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine |
|---|---|
| PubChem CID | 121275228 |
| Molecular Formula | C24H22N6S |
| Molecular Weight | 426.55 g/mol |
| Exact Mass | 426.16 |
| IUPAC Name | N-[(1S)-2,3-dihydro-1H-inden-1-yl]-6-[[5-(1-methylpyrazol-4-yl)imidazol-1-yl]methyl]-1,3-benzothiazol-2-amine |
| SMILES | Cn1cc(-c2cncn2Cc2ccc3nc(N[C@H]4CCc5ccccc54)sc3c2)cn1 |
| InChI | InChI=1S/C24H22N6S/c1-29-14-18(11-26-29)22-12-25-15-30(22)13-16-6-8-21-23(10-16)31-24(28-21)27-20-9-7-17-4-2-3-5-19(17)20/h2-6,8,10-12,14-15,20H,7,9,13H2,1H3,(H,27,28)/t20-/m0/s1 |
| InChIKey | ZBORYIVHHMXULS-FQEVSTJZSA-N |
| XLogP | 5.04 |
| TPSA | 60.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.55 |
| LogP ≤ 5 | 5.04 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121275228 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.